Skip to main content
ArticleOPEN ACCESS

Correction: Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come (Molecular Neurodegeneration, (2023), 18, 1, (74), 10.1186/s13024-023-00663-y)

Molecular Neurodegeneration
DOI: 10.1186/s13024-023-00678-5
0Citations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the original article [1] the following statement of funding acknowledgement was mistakenly omitted: “Preclinical studies have been supported by NIH grants P01AG017617 and R01AG062376 grants to RAN.”.

Cite

CITATION STYLE

APA

Alam, J. J., & Nixon, R. A. (2023, December 1). Correction: Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come (Molecular Neurodegeneration, (2023), 18, 1, (74), 10.1186/s13024-023-00663-y). Molecular Neurodegeneration. BioMed Central Ltd. https://doi.org/10.1186/s13024-023-00678-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free